1[1]Gressner AM. Bachem MG. Molecular mechanisms of fibrogenesis-A homage to the role of activated fat-storing cells.Digestion, 1995,56:335～346
2[2]Alcolaolo R, Arthur M J, Iredale JP. Pathogenesis of liver fibrosis. Clon Sci Colch, 1997,92:103～112
3[3]Vawada N. The hepatic prerisinusoidal stellate cell. Histol Histopathol, 1997,12:1069～1080
4[4]E A El Att, F Nevens. Variceal pressure is a strong predictor of Variceal haemorrhage in patients with cirrhosis as in patients with non-cirrhotic fortal hypertension. J Gastroenterol Hepatol,1999,4,618～621
5[5]Trotter JF, Brenner DA. Current and prospective therapies for hepatic fibrosis. Comper Ther, 1995,21:303～307
6[6]Racker L. Protective role of vitamin E in biological systems Am J clin Nutr, 1991,53:1050～1055
7[7]Border WA, Noble NA, Trunsforming grouth foctor beta in tissue fibrosis. New Engl. J Med, 1994,331:1286～1292
8[8]Forbes S J, Hodgson HJ. Gene therapy in gastrontrdogy and hepdogy. Aliment pharmacol ther, 1997,11:823～836
9[9]Wu CH Targeted inhibition of type I proldlagen synthesis by antisense DNA digonudeitides. International hepatology communications-31t annual meeting of the Japan society of hepatology. July 21～23,1995,FuKuKa, Japan 1995,Vo13 suppl522
2Hatz C,Murakami H,Jenkins JM. A review of the literature on the use of uhrasonography in schistosomiasis with special reference to its use in fieid studies.3.schistosoma japonicum.Acta Tropica, 1992,51:29.
